|
|
|
|
|
|
Free Newsletters
Archive
My eNewsletters
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Login
Become a Member
Discussion Forums
FAQ
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Career Definitions
Labor Market Reports
Education & Training
Regions
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
Genital Herpes Treatment Does Not Prevent HIV, University of Washington Study
8/12/2008
MEXICO CITY (Reuters Health) - Long-term treatment of genital herpes with the drug acyclovir does not reduce the rate of new HIV infections, researchers reported at the International AIDS Conference here last week. They said the findings are surprising, because prior infection with herpes simplex virus type 2 (HSV-2), the virus that causes genital herpes, has been reported to increase the risk of HIV many fold. In a randomized multicenter trial, Dr. C. Celum of the University of Washington, Seattle, and colleagues evaluated the effects of acyclovir in 1,814 gay men who have sex with men from the United States and Peru, and in 1,358 women from Zimbabwe, Zambia and South Africa. All were infected with HSV-2 but not with HIV, the virus that causes AIDS.
|
|
|
|
|
|
|
|
|
|
|
|